"Interlocking Drug Infusion Device And Artificial Pancreas" in Patent Application Approval Process (USPTO 20240316259).

A patent application by inventor Cuijun Yang has been made available online for an interlocking drug infusion device and artificial pancreas. The device aims to prevent over-infusion of insulin in diabetic patients by using a program module and position detection module to provide driving instructions to the actuator. This interlock mechanism ensures that the device continues to function even in the event of electronic component failure, reducing the risk of hypoglycemia or coma. The invention also includes an elastic member to reset the driving unit and various arrangements for the position detection element. The patent application was filed by Medtrum Technologies Inc. and is part of ongoing efforts to improve diabetes management technology. [Extracted from the article]